Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: CFD RESEARCH CORPORATION
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2022-02-01 to 2024-05-31
Current total value of award: $1099895
Description: AWARD OF CFD'S DHA STTR PHASE II MEDICAL R&D CONTRACT FOR "DEVELOP AND DEMONSTRATE A TECHNOLOGY FOR ISOLATION OF BACTERIOPHAGES WITH ENHANCED ANTIBIOFILM ACTIVITY"